Maloney and Pallone Release Staff Report on Review, Approval, and Pricing of Biogen's Alzheimer's Drug Aduhelm
December 30, 2022
December 30, 2022
WASHINGTON, Dec. 30 -- Rep. Frank Pallone Jr., D-New Jersey, chairman of the House Energy and Commerce Committee, issued the following news release:
Oversight and Reform Committee Chairwoman Carolyn B. Maloney (D-NY) and Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released a staff report following an 18-month investigation into the Food and Drug Administration's (FDA) regulatory review and approval process of Biogen's Alzheimer's disease drug Aduh . . .
Oversight and Reform Committee Chairwoman Carolyn B. Maloney (D-NY) and Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released a staff report following an 18-month investigation into the Food and Drug Administration's (FDA) regulatory review and approval process of Biogen's Alzheimer's disease drug Aduh . . .